The Valley Desk

NCT07850609 · Interventional trial

A Clinical Study of Alimatravir (MK-8527) in Transgender (Trans) and Gender Diverse Individuals on Gender-affirming Hormone Therapy and at Low Likelihood of Human Immunodeficiency Virus (HIV)-1 Exposure (MK-8527-018)

Overall registry status Recruiting

Phase 2

Conditions HIV

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov